Antihypertensive drug class and dyslipidemia: Risk association among Chinese patients with uncomplicated hypertension

Journal of Human Hypertension

Volumn 22, Issue 9, 2008, Pages 648-651

  Wong, M C S ^a   Jiang, J Y ^a   Ali, M K ^a   Fung, H ^b   Griffiths, S ^a   Mercer, S W ^a,c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THIAZIDE DIURETIC AGENT; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHINESE; CHOLESTEROL BLOOD LEVEL; DYSLIPIDEMIA; FEMALE; HONG KONG; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CHOLESTEROL; DYSLIPIDEMIAS; FEMALE; HUMANS; MALE; MIDDLE AGED; RENIN-ANGIOTENSIN SYSTEM; THIAZIDES;

EID: 50449094320     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2008.46     Document Type: Article

References (12)

1. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA 1987; 257: 2176-2180.
2. Borghi C, Dormi A, Veronesi M, Sangiorgi Z, Gaddi A. Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study. Am Heart J 2004; 148: 285-292.
3. Halperin RO, Sesso HD, Ma J, Buring JE, Stampfer MJ, Gaziano JM. Dyslipidemia and the risk of incident hypertension in men. Hypertension 2006; 47: 45-50.
4. Kasiske BL, Ma JZ, Kalil RS, Louis TA. Effects of antihypertensive therapy on serum lipids. Ann Intern Med 1995; 122: 133-141.
5. Moser M. Current hypertension management: Separating fact from fiction. Cleve Clin J Med 1993; 60: 27-37.
6. Cheung NT. Health informatics, hospital authority, Hong Kong. Realizing the benefits of eHealth in Hong Kong. Available at: http://www.ehealth.org.hk/Speaker/Dr%20Ngai%20Tseung%20CHEUNG.pdf, accessed on 19 September 2007.
7. Friedewald WT, Levy RI, Fredrickson DS. Estimation of plasma low density lipoprotein cholesterol concentration without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-512.
8. Lip GYH, Hall JE. Compr Hypertens. Mosby Inc.: USA, 2007.
9. Williams R, Schneider KA, Borhani NO, Schnaper HW, Slotkoff LM, Ellefson RD. The relationship between diuretics and serum cholesterol in hypertension detection and follow-up program participants. Am J Prev Med 1986; 2: 248-255.
10. Kasiske BL, Ma JZ, Kalil RS, Louis TA. Effects of antihypertensive therapy on serum lipids. Ann Intern Med 1995; 122: 133-141.
11. Kesteloot H, Huang DX, Yang XS, Claes J, Rosseneu M, Geboers J et al. Serum lipids in the people's republic of china, comparison of western and eastern populations. Arteriosclerosis 1985; 5: 427-433.
12. Cai HJ, Li ZX, Yang SM. Serum high density lipoprotein cholesterol levels in Chinese healthy subjects and patients with certain diseases. Atherosclerosis 1982; 43: 197-207.